Published in Hospital Business Week, May 27th, 2007
This trend article about Toho University, Japan, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome," is the subject of a report. According to a study from Chiba, Japan, "Lipoprotein lipase mass in preheparin serum (preheparin LPL mass) is assumed to reflect some of the LPL production in the whole body and insulin sensitivity. While metabolic syndrome is a common underlying condition for cardiovascular diseases, biological marker of this syndrome...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.